• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

位于外环的HLA - DRα链残基参与非多态性和多态性抗体结合表位。

HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes.

作者信息

Fu X T, Karr R W

机构信息

Department of Immunology and Infectious Diseases, Monsanto Company, St. Louis, Missouri 63198.

出版信息

Hum Immunol. 1994 Apr;39(4):253-60. doi: 10.1016/0198-8859(94)90268-2.

DOI:10.1016/0198-8859(94)90268-2
PMID:7520896
Abstract

The structure-function relationships of the HLA-DR alpha chain have been analyzed by identifying DR alpha residues involved in several nonpolymorphic and polymorphic antibody epitopes. Antibody binding to transfectants expressing a WT or mutant DR alpha chain with the WT DR(beta 1*0701) chain was analyzed. Our results indicate that residues 18, 36, and 39 located on the outer loops of the DR alpha chain are critical for one or more of the epitopes recognized by the SG157, Q2/70, L243, LB3.1, D1-12, and CL413 mAbs. Similar results were obtained when the DR alpha position 18 and 39 mutants were expressed with other DR beta 1 alleles. Furthermore, residues 15 and 18 of the DR alpha chain were shown to be involved in the epitopes of two polymorphic mAbs, HU-26 and I-2, whose epitopes also include residue 4 of the corresponding DR beta chains. In addition to their involvement in antibody-binding epitopes, residues in this region on the outer surface of the DR alpha chain have also been shown to be involved in superantigen binding and presentation and T-cell recognition of foreign antigen, emphasizing the functional importance of DR alpha-chain residues located outside of the peptide-binding groove.

摘要

通过鉴定参与几种非多态性和多态性抗体表位的DRα残基,对HLA - DRα链的结构 - 功能关系进行了分析。分析了抗体与表达野生型(WT)或突变型DRα链以及野生型DR(β1 * 0701)链的转染子的结合情况。我们的结果表明,位于DRα链外环上的第18、36和39位残基对于SG157、Q2 / 70、L243、LB3.1、D1 - 12和CL413单克隆抗体识别的一个或多个表位至关重要。当DRα第18和39位突变体与其他DRβ1等位基因一起表达时,也获得了类似的结果。此外,DRα链的第15和18位残基被证明参与了两种多态性单克隆抗体HU - 26和I - 2的表位,其表位还包括相应DRβ链的第4位残基。除了参与抗体结合表位外,DRα链外表面该区域的残基还被证明参与超抗原结合与呈递以及对外源抗原的T细胞识别,这突出了位于肽结合槽外部的DRα链残基的功能重要性。

相似文献

1
HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes.位于外环的HLA - DRα链残基参与非多态性和多态性抗体结合表位。
Hum Immunol. 1994 Apr;39(4):253-60. doi: 10.1016/0198-8859(94)90268-2.
2
HLA-DR residues accessible under the peptide-binding groove contribute to polymorphic antibody epitopes.肽结合槽下可及的HLA - DR残基有助于形成多态性抗体表位。
Hum Immunol. 1995 Aug;43(4):243-50. doi: 10.1016/0198-8859(95)00036-4.
3
HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes.预计位于肽结合槽底部的HLA - DRβ链残基有助于形成抗体结合表位。
Hum Immunol. 1993 May;37(1):51-8. doi: 10.1016/0198-8859(93)90142-n.
4
Critical role of HLA-DR beta 1 residue 58 in multiple polymorphic epitopes recognized by xenogeneic and allogeneic antibodies.HLA-DRβ1第58位残基在异种和同种异体抗体识别的多个多态性表位中的关键作用
Hum Immunol. 1992 Sep;35(1):18-28. doi: 10.1016/0198-8859(92)90091-z.
5
Identification of residues involved in polymorphic antibody binding epitopes on HLA-DR molecules.鉴定参与HLA-DR分子多态性抗体结合表位的残基。
Hum Immunol. 1992 Jan;33(1):47-56. doi: 10.1016/0198-8859(92)90051-n.
6
Transfer of polymorphic monoclonal antibody epitopes to the first and second domains of HLA-DR beta-chains by site-directed mutagenesis.
J Immunol. 1991 Jan 15;146(2):621-6.
7
Diverse locations of amino acids in HLA-DR beta chains involved in polymorphic antibody binding epitopes on DR(alpha, beta 1*0101), DR(alpha, beta 1*1101), and DR(alpha,beta 3*0202) molecules.参与与DR(α,β1*0101)、DR(α,β1*1101)和DR(α,β3*0202)分子上多态性抗体结合表位相关的HLA - DRβ链中氨基酸的不同位置。
Hum Immunol. 1992 Mar;33(3):193-201. doi: 10.1016/0198-8859(92)90071-t.
8
Acidic residues in the DR beta chain third hypervariable region are required for stimulation of a DR(alpha, beta 1*0402)-restricted T-cell clone.刺激DR(α,β1*0402)限制性T细胞克隆需要DRβ链第三高变区中的酸性残基。
Hum Immunol. 1994 Nov;41(3):193-200. doi: 10.1016/0198-8859(94)90036-1.
9
Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.HLA-DR(α,β1*0401)分子的口袋4是T细胞识别肽段的主要决定因素。
J Exp Med. 1995 Mar 1;181(3):915-26. doi: 10.1084/jem.181.3.915.
10
New polymorphic HLA-DR epitopes recognized by three monoclonal antibodies produced against DR103 transfected L cells.
Tissue Antigens. 1992 Oct;40(4):197-203. doi: 10.1111/j.1399-0039.1992.tb02045.x.

引用本文的文献

1
Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.盐酸千金藤碱通过 HLA-DR3 阻断 TSH 受体肽的呈递:对格雷夫斯病的治疗意义。
J Autoimmun. 2020 Mar;108:102402. doi: 10.1016/j.jaut.2020.102402. Epub 2020 Jan 21.
2
The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines.人类单核细胞中的主要组织相容性复合体II类抗原呈递途径因亚群而异,并受细胞因子调节。
PLoS One. 2017 Aug 23;12(8):e0183594. doi: 10.1371/journal.pone.0183594. eCollection 2017.
3
Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
HLA-DR对柔性肽的识别在自身免疫性甲状腺炎和糖尿病中引发特定的自身免疫性T细胞反应。
J Autoimmun. 2017 Jan;76:1-9. doi: 10.1016/j.jaut.2016.09.007. Epub 2016 Sep 23.
4
Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis.鉴定一种可阻断自身免疫性甲状腺炎中抗原呈递的小分子
J Biol Chem. 2016 Feb 19;291(8):4079-90. doi: 10.1074/jbc.M115.694687. Epub 2015 Dec 24.
5
Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.对HLA - DM蛋白的易感性由与肽结合的主要组织相容性复合体II类分子的动态构象决定。
J Biol Chem. 2014 Aug 22;289(34):23449-64. doi: 10.1074/jbc.M114.585539. Epub 2014 Jul 7.
6
Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells.抗 HIV 设计 T 细胞通过顺序诱导 HIV 再激活然后杀伤新的 gp120 阳性细胞,从而逐渐清除潜伏感染的细胞系。
Virology. 2013 Nov;446(1-2):268-75. doi: 10.1016/j.virol.2013.08.002. Epub 2013 Sep 6.
7
MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.用带有亲和标签的肽重新折叠的分离重组α和β链制成的 MHC Ⅱ类四聚体。
PLoS One. 2013 Sep 2;8(9):e73648. doi: 10.1371/journal.pone.0073648. eCollection 2013.
8
Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loading.用于研究MHC II类生物合成、成熟和肽装载的脉冲追踪分析。
Methods Mol Biol. 2013;960:411-432. doi: 10.1007/978-1-62703-218-6_31.
9
Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.Ⅱ类转录激活物(CIITA)增强 HIV-1 Pr55Gag 的细胞质加工。
PLoS One. 2010 Jun 24;5(6):e11304. doi: 10.1371/journal.pone.0011304.
10
Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.利用重组HLA - DR3表达系统剖析主要组织相容性复合体II - 甲状腺球蛋白肽的动态变化:遗传学、生物化学及反向免疫学视角
J Biol Chem. 2009 Dec 4;284(49):34231-43. doi: 10.1074/jbc.M109.041574. Epub 2009 Sep 23.